Understanding the association between M2 macrophages, CCL18 expression, and CREM provides valuable insights into the underlying mechanisms driving HCC development and paves the way for targeted interventions to combat this aggressive cancer. This evidence concerns the gene CCL18 and hepatocellular carcinoma.